Advisor Group’s Sophiris Bio, Inc. SPHS Stock Holding History

Advisor Group’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$2K	Hold	6,000	–	–	﹤0.01%	5073
2019 Q3	$4K	Hold	6,000	–	–	﹤0.01%	4802
2019 Q2	$5K	Hold	6,000	–	–	﹤0.01%	4727
2019 Q1	$6K	Hold	6,000	–	–	﹤0.01%	4643
2018 Q4	$5K	Buy	6,000 +3,000	+100%	+$5.9K	﹤0.01%	4573
2018 Q3	$8K	Buy	3,000 +2,000	+200%	+$5.69K	﹤0.01%	4429
2018 Q2	$3K	Sell	1,000 -1,392	-58%	-$4.13K	﹤0.01%	4619
2018 Q1	$5K	Hold	2,392	–	–	﹤0.01%	4467
2017 Q4	$5K	Sell	2,392 -685	-22%	-$1.49K	﹤0.01%	4464
2017 Q3	$7K	Buy	3,077 +92	+3%	+$191	﹤0.01%	4171
2017 Q2	$7K	Buy	2,985 +985	+49%	+$2.41K	﹤0.01%	4142
2017 Q1	$6K	Buy	+2,000	New	+$5.48K	﹤0.01%	4083

Other funds holding SPHS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Advisor Group's SPHS Position: Q4 2019 in Review

Advisor Group held its Sophiris Bio, Inc. (SPHS) position steady in Q4 2019 at 6,000 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #5073.

Advisor Group first reported a position in SPHS in Q1 2017 and has held it in 12 quarters since. The position peaked at $8K in Q3 2018. 27 funds tracked by Wall St. Rank hold SPHS as of Q4 2019.

Advisor Group held 6,000 shares of Sophiris Bio, Inc. worth $2K as of Q4 2019.
Advisor Group left its Sophiris Bio, Inc. share count unchanged in Q4 2019.
Sophiris Bio, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5073 holding.
Advisor Group first reported a position in Sophiris Bio, Inc. in Q1 2017 and has held it in 12 quarters since.
Advisor Group's Sophiris Bio, Inc. position peaked at $8K in Q3 2018.
27 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.